loadpatents
Patent applications and USPTO patent grants for Lalonde; Guy.The latest application filed is for "oligomer-cannabinoid conjugates".
Patent | Date |
---|---|
Oligomer-cannabinoid conjugates Grant 9,155,797 - Riggs-Sauthier , et al. October 13, 2 | 2015-10-13 |
Oligomer-cannabinoid Conjugates App 20140329895 - Riggs-Sauthier; Jennifer ;   et al. | 2014-11-06 |
Oligome-cannabinoid conjugates Grant 8,829,043 - Riggs-Sauthier , et al. September 9, 2 | 2014-09-09 |
Peptides that bind to the erythropoietin receptor Grant 8,729,030 - Holmes , et al. May 20, 2 | 2014-05-20 |
Novel Peptides That Bind To The Erythropoietin Receptor App 20130244939 - Holmes; Christopher P. ;   et al. | 2013-09-19 |
Peptides That Bind To The Erythropoietin Receptor App 20130130979 - Holmes; Christopher P. ;   et al. | 2013-05-23 |
Novel Peptides That Bind To The Erythropoietin Receptor App 20130012685 - Holmes; Christopher P. ;   et al. | 2013-01-10 |
Peptides that bind to the erythropoietin receptor Grant 8,304,391 - Holmes , et al. November 6, 2 | 2012-11-06 |
Vaccine Having a Peptide Adjuvant for Eliciting a Specific Immune Response to Treat Viral Infection and Other Conditions App 20120231025 - Sahner; David ;   et al. | 2012-09-13 |
Novel Peptides That Bind To The Erythropoietin Receptor App 20120157660 - Holmes; Christopher P. ;   et al. | 2012-06-21 |
Oligomer-Cannabinoid Conjugates App 20120022063 - Riggs-Sauthier; Jennifer ;   et al. | 2012-01-26 |
Novel Peptides That Bind To The Erythropoietin Receptor App 20110282029 - Holmes; Christopher P. ;   et al. | 2011-11-17 |
Novel Peptides That Bind To The Erythropoietin Receptor App 20110245176 - Holmes; Christopher P. ;   et al. | 2011-10-06 |
Peptides that bind to the erythropoietin receptor Grant 7,855,175 - Holmes , et al. December 21, 2 | 2010-12-21 |
Peptides That Bind To The Erythropoietin Receptor App 20090227508 - Holmes; Christopher P. ;   et al. | 2009-09-10 |
Peptides that bind to the erythropoietin receptor Grant 7,528,104 - Holmes , et al. May 5, 2 | 2009-05-05 |
Novel Peptides That Bind To The Erythropoietin Receptor App 20090048166 - Holmes; Christopher P. ;   et al. | 2009-02-19 |
Novel Peptides that Bind to the Erythropoietin Receptor App 20090005292 - Holmes; Christopher P. ;   et al. | 2009-01-01 |
Peptides that bind to the erythropoietin receptor Grant 7,414,105 - Holmes , et al. August 19, 2 | 2008-08-19 |
Novel Peptides That Bind To The Erythropoietin Receptor App 20080108564 - Holmes; Christopher P. ;   et al. | 2008-05-08 |
Novel peptides that bind to the erythropoietin receptor App 20070027074 - Holmes; Christopher P. ;   et al. | 2007-02-01 |
Peptides that bind to the erythropoietin receptor Grant 7,084,245 - Holmes , et al. August 1, 2 | 2006-08-01 |
Novel peptides that bind to the erythropoietin receptor App 20060040858 - Holmes; Christopher P. ;   et al. | 2006-02-23 |
Novel peptides that bind to the erythropoietin receptor App 20050137329 - Holmes, Christopher P. ;   et al. | 2005-06-23 |
Hemolysin fusion proteins, their production and use App 20020001593 - O'Hanley, Peter ;   et al. | 2002-01-03 |
Nano-grid micro reactor and methods Grant 6,309,889 - Cutler , et al. October 30, 2 | 2001-10-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.